Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAPI-PET in Malignant Tumors
NCT05442151Recruiting
- Start
- May 2022
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of [18F]-FAPI-74 in Neoplasm. Primary endpoints: Comparison of the uptake on FAPI-PET with conventional imaging at 2 hours, Comparison with pathological specimens at 1 month and 1 more. Started May 2022; status: recruiting.
02
Drugs
[18F]-FAPI-74
03
Conditions
Neoplasm
Beyond the preview
Go deeper on NCT05442151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05442151.